✦ LIBER ✦

Platelet-sparing effect of paclitaxel in heavily pretreated ovarian cancer patients

✍ Scribed by H. Ishikawa; K. Fujiwara; S. Suzuki; Y. Tanaka; I. Kohno

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly paclitaxel in heavily pretreated

✍ GianMaria Miolo; Ettore Bidoli; Davide Lombardi; Davide Adriano Santeufemia; Gia 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 170 KB

Salvage therapy with topotecan in heavil

✍ Lubomir Bodnar; Gabriel Wcislo; Anna Nasilowska; Katarzyna Szarlej-Wcislo; Agnie 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 314 KB

Phase II study of single-agent gemcitabi

✍ Yoh Watanabe; Eiji Koike; Hidekatsu Nakai; Tomomaro Etoh; Hiroshi Hoshiai 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 237 KB

Feasibility study of oral cyclophosphami

✍ Yoh Watanabe; Tomomaro Etoh; Eiji Koike; Yoshiaki Mizuno; Wei-Min Wang; Hiroshi 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 141 KB

Long-term disease-free survival effected

✍ Benjamin Piura 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 56 KB

The platelet-sparing effect of paclitaxe

✍ Keiichi Fujiwara; Hideaki Yamauchi; Sachiko Suzuki; Hiroyasu Ishikawa; Yasumasa 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 84 KB